Although it has not yet been placed on the Vitro Biopharma website, you can find some additional information about VODG's cell culture media (now branded "MSCGro") on HemoGenix's new website which came online recently......
Regarding the private message I received recently, asking if I know anything about the identity of the offshore third party interested in VODG's fertility drug technology. Although this is purely a guess on my part, the term "renewed interest" (see below) leads me to believe that maybe BioCare Europe has been expressing interest in the technology again.
BioCare Europe (an Italian biotech company founded and run by Dr. Luca Trama) was publicly acknowledged by VODG some 5+ years ago as being interested in VODG's fertility drug platform. I think BioCare Europe uses FSH (follicle-stimulating hormone) in some of its products, and I recall seeing the company participated in the funding of some fertility-related clinical trials along with Merck Serono (which controls a large segment of the FSH market).
But, again, that is just my best guess at the moment.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.